Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease

Fulltext:
179606.pdf
Embargo:
until further notice
Size:
371.6Kb
Format:
PDF
Description:
publisher's version
Publication year
2017Source
Clinical Pharmacology and Therapeutics, 102, 6, (2017), pp. 1017-1024ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Pathology
Human Genetics
Internal Medicine
Journal title
Clinical Pharmacology and Therapeutics
Volume
vol. 102
Issue
iss. 6
Page start
p. 1017
Page end
p. 1024
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences; Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 7: Neurodevelopmental disorders DCMN: Donders Center for Medical Neuroscience; Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [204968]
- Electronic publications [103219]
- Faculty of Medical Sciences [81049]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.